Cargando…
Defining the Design Parameters for in Vivo Enzyme Delivery Through Protein Spherical Nucleic Acids
[Image: see text] The translation of proteins as effective intracellular drug candidates is limited by the challenge of cellular entry and their vulnerability to degradation. To advance their therapeutic potential, cell-impermeable proteins can be readily transformed into protein spherical nucleic a...
Autores principales: | Kusmierz, Caroline D., Bujold, Katherine E., Callmann, Cassandra E., Mirkin, Chad A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2020
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7256953/ https://www.ncbi.nlm.nih.gov/pubmed/32490197 http://dx.doi.org/10.1021/acscentsci.0c00313 |
Ejemplares similares
-
Impact of Liposomal Spherical Nucleic Acid Structure
on Immunotherapeutic Function
por: Callmann, Cassandra E., et al.
Publicado: (2021) -
Disrupting the
Interplay between Programmed Cell Death
Protein 1 and Programmed Death Ligand 1 with Spherical Nucleic Acids
in Treating Cancer
por: Chou, Liyushang, et al.
Publicado: (2022) -
Spherical nucleic acids as an infectious disease vaccine platform
por: Teplensky, Michelle H., et al.
Publicado: (2022) -
Spherical nucleic acids for precision medicine
por: Mirkin, Chad A., et al.
Publicado: (2013) -
Design Considerations for RNA Spherical Nucleic Acids
(SNAs)
por: Barnaby, Stacey N., et al.
Publicado: (2016)